The following webcasts are scheduled. Participation is free, so please register to participate.
Please be aware that Webinars are hosted through GoToWebinar. If you are not already set up to view webinars through this service, please allow 5 minutes before the start of the webinar to establish access.
Date: June 10th, 2015 16: 00-16: 45 GMT (London time)
Presenter: Dr Richard Rickles, Senior Director of Oncology As a result of induced changes in signaling transduction pathways after drug treatment (or presence of redundant survival pathways) there are a multitude of ways through which the effects of drugs designed to potently and selectively kill cancer cells are blunted. Therefore, the discovery of drug combinations that circumvent adaptive responses is critical path for identification of maximally effective cancer treatments. In this webinar, we will discuss: - Horizon’s Pathfinder combination high throughput screening (cHTS) platform, which is capable of screening large numbers of drug combinations in a short period of time - Use of our platform and a panel of more than 1300 cell lines to identify drug combination that synergistically and selectively kill tumor cells - Our proprietary Chalice™ analytics software and potential follow up experiments after a primary screen
Date: June 25th, 2015 16: 00-16: 40 GMT (London time)
Key Topics Key difficulties and solutions in mapping GRCh37 to GRCh38 The effect of FFPE artefacts on variant calling The use of Genome In A Bottle (GIAB) reference materials in bioinformatics Answers to the Top 5’ questions asked by customers and answered by our in-house technical experts
Paragraph explaining benefits of Biocair×